{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:22:17Z","timestamp":1792664537869,"version":"4.5.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Neuropathic Pain Symptom Inventory (NPSI) is a commonly used assessment in neuropathic pain (NP) trials, yet a Minimal Clinically Important Difference (MCID) has not been established. An MCID would enhance the interpretability of NPSI scores, guiding clinicians and researchers in assessing clinically important improvements in NP symptoms. The aim of this study was to calculate an MCID from the available scientific research that used the NPSI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review and meta-analysis of NP trials reporting the NPSI. Four distributional approaches were applied to estimate the MCID: 1) meta-regression on the set of standard deviation (SD) of change scores, 2) meta-regression on the set of baseline SD scores, 3) simple aggregation on the set of SD of change scores, and 4) simple aggregation on the set of baseline SD scores. Only treatment arms within Randomized Controlled Trials (RCTs) were examined for MCID estimation. Control arms were examined separately in a sensitivity analysis using the simple aggregation method for both SD of change and baseline SD sets. Bias for each included study was assessed using the Cochrane tool for quality assessment of randomized controlled trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>323 trials were examined, 12 were selected for inclusion with a total of 17 treatment arms. The calculated MCID estimates for the NPSI total score (range 1\u2013100) were 6.21 for the SD of change meta-regression and 7.1 for baseline SD meta regression. The MCID values aggregated using simple aggregation methods were 7.95 using pooled SD of change scores, 7.8 using pooled baseline SD. Control arms had a MCID of 8.04 for SD of Change and 8.71 for Baseline SD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides preliminary MCID estimates for the NPSI. Limitations include limited data for NP subtypes, highlighting the need for additional anchor-based and etiology-specific MCID research to refine these estimates. These findings can aid in future NP trial design and the interpretation of results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42025649343<\/jats:ext-link>\n                      , PROSEPRO CRD42025649343.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpain.2025.1637741","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T06:36:33Z","timestamp":1767940593000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Initial estimates of the minimal clinically important difference for the Neuropathic Pain Symptom Inventory: a systematic meta-analysis"],"prefix":"10.3389","volume":"6","author":[{"given":"Alexandra","family":"Canori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Bower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Putrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tabacof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1111\/j.1533-2500.2007.00164.x","article-title":"A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions","volume":"14","author":"Sadosky","year":"2013","journal-title":"Pain Pract"},{"key":"B4","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"van Hecke","year":"2014","journal-title":"Pain"},{"key":"B5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","article-title":"Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the international classification of diseases (ICD-11)","volume":"160","author":"Treede","year":"2019","journal-title":"Pain"},{"key":"B6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","article-title":"The IASP classification of chronic pain for ICD-11: chronic neuropathic pain","volume":"160","author":"Scholz","year":"2019","journal-title":"Pain"},{"key":"B7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/AJP.0000000000001001","article-title":"Prediction of individual analgesic response to intravenous lidocaine in painful diabetic peripheral neuropathy: a randomized, placebo-controlled, crossover trial","volume":"38","author":"Todorovic","year":"2022","journal-title":"Clin J Pain"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e1193","DOI":"10.1212\/WNL.0000000000201709","article-title":"Mirogabalin for central neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled, phase 3 study in Asia","volume":"100","author":"Ushida","year":"2023","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41393-022-00806-w","article-title":"Effects of whole-body vibration on neuropathic pain and the relationship between pain and spasticity in persons with spinal cord injury","volume":"60","author":"Wong","year":"2022","journal-title":"Spinal Cord"},{"key":"B10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-981-99-8921-8_12","article-title":"Update in the treatment of neuropathic pain","volume-title":"Translational Research in Pain and Itch","author":"Zhang","year":"2024"},{"key":"B11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S1474-4422(18)30071-1","article-title":"Diagnosis and assessment of neuropathic pain through questionnaires","volume":"17","author":"Attal","year":"2018","journal-title":"Lancet Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jpain.2004.09.001","article-title":"Neuropathic pain symptoms relative to overall pain rating","volume":"5","author":"Backonja","year":"2004","journal-title":"J Pain"},{"key":"B13","first-page":"14","article-title":"Diagnosis and classification of neuropathic pain","volume":"150","author":"Haanp\u00e4\u00e4","year":"2010","journal-title":"Pain"},{"key":"B14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pain.2004.12.010","article-title":"Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)","volume":"114","author":"Bouhassira","year":"2005","journal-title":"Pain"},{"key":"B15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.pain.2010.07.031","article-title":"NeuPSIG guidelines on neuropathic pain assessment","volume":"152","author":"Haanp\u00e4\u00e4","year":"2011","journal-title":"Pain"},{"key":"B16","year":""},{"key":"B17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status: ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Control Clin Trials"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1037\/a0024338","article-title":"Effect size estimates: current use, calculations, and interpretation","volume":"141","author":"Fritz","year":"2012","journal-title":"J Exp Psychol Gen"},{"key":"B19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/gps.2607","article-title":"Determining the minimum clinically important differences for outcomes in the DOMINO trial","volume":"26","author":"Howard","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.spinee.2007.01.008","article-title":"Understanding the minimum clinically important difference: a review of concepts and methods","volume":"7","author":"Copay","year":"2007","journal-title":"Spine J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1586\/erp.11.12","article-title":"Interpreting patient-reported outcome results: US FDA guidance and emerging methods","volume":"11","author":"McLeod","year":"2011","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"B23","year":"2009"},{"key":"B24","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life. The remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care"},{"key":"B25","article-title":"Chapter 8: assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0)","author":"Higgins","year":"2011"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/j.pain.2014.08.015","article-title":"Thoracic sympathetic block for the treatment of complex regional pain syndrome type I: a double-blind randomized controlled study","volume":"155","author":"de Oliveira Rocha","year":"2014","journal-title":"Pain"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.4239\/wjd.v14.i12.1813","article-title":"Acupuncture in diabetic peripheral neuropathy-neurological outcomes of the randomized acupuncture in diabetic peripheral neuropathy trial","volume":"14","author":"Hoerder","year":"2023","journal-title":"World J Diabetes"},{"key":"B28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.pmn.2017.07.003","article-title":"Management of sickle cell pain using pregabalin: a pilot study","volume":"18","author":"Schlaeger","year":"2017","journal-title":"Pain Manag Nurs"},{"key":"B29","doi-asserted-by":"publisher","first-page":"BIO52","DOI":"10.1167\/iovs.16-21291","article-title":"Cibinetide improves corneal nerve fiber abundance in patients with sarcoidosis-associated small nerve fiber loss and neuropathic pain","volume":"58","author":"Culver","year":"2017","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1185\/03007995.2010.483675","article-title":"Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study","volume":"26","author":"Rehm","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e31296","DOI":"10.1097\/MD.0000000000031296","article-title":"Postoperative analgesia of intraoperative nefopam in patients undergoing anterior cervical spine surgery: a prospective randomized controlled trial","volume":"101","author":"Raksakietisak","year":"2022","journal-title":"Medicine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.bjps.2016.07.003","article-title":"Fat grafting for alleviating persistent pain after breast cancer treatment: a randomized controlled trial","volume":"69","author":"Juhl","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.pain.2013.03.028","article-title":"The efficacy of a glial inhibitor, minocycline, for preventing persistent pain after lumbar discectomy: a randomized, double-blind, controlled study","volume":"154","author":"Martinez","year":"2013","journal-title":"Pain"},{"key":"B35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3233\/NRE-192958","article-title":"Effects of multi-session intermittent theta burst stimulation on central neuropathic pain: a randomized controlled trial","volume":"46","author":"Kim","year":"2020","journal-title":"NeuroRehabilitation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0304-3959(96)02994-6","article-title":"Patients\u2019 memories of painful medical treatments: real-time and retrospective evaluations of two minimally invasive procedures","volume":"66","author":"Redelmeier","year":"1996","journal-title":"Pain"},{"key":"B37","volume-title":"R: A Language and Environment for Statistical Computing","year":"2023"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-021-01228-7","article-title":"Using a distribution-based approach and systematic review methods to derive minimum clinically important differences","volume":"21","author":"Watt","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10072-011-0498-3","article-title":"Exploring neuropathic symptoms in a large cohort of Italian patients with different peripheral nervous system diseases","volume":"32","author":"Lucchetta","year":"2011","journal-title":"Neurol Sci"}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2025.1637741\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T06:36:37Z","timestamp":1767940597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2025.1637741\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":40,"alternative-id":["10.3389\/fpain.2025.1637741"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2025.1637741","relation":{},"ISSN":["2673-561X"],"issn-type":[{"value":"2673-561X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"article-number":"1637741"}}